In light of these findings, we suggest that HCC patients with lower pre-treatment PNI, higher DB, ALP, AFP, and γ-GT /ALT levels may be potential candidates for micro-BDTT before surgery. The gene discussed is GPT; the disease is hepatocellular carcinoma.